It is widely accepted that unrepaired or misrepaired DNA double strand breaks (DSBs) lead to the formation of chromosome aberrations. DSBs induced in the DNA of higher eukaryotes by endogenous processes or exogenous agents can in principle be repaired either by non-homologous endjoining (NHEJ), or homology directed repair (HDR). The basis on which the selection of the DSB repair pathway is made remains unknown but may depend on the inducing agent, or process. Evaluation of the relative contribution of NHEJ and HDR specifically to the repair of ionizing radiation (IR) induced DSBs is important for our understanding of the mechanisms leading to chromosome aberration formation. Here, we review recent work from our laboratories contributing to this line of inquiry. Analysis of DSB rejoining in irradiated cells using pulsed-field gel electrophoresis reveals a fast component operating with half times of 10–30 min. This component of DSB rejoining is severely compromised in cells with mutations in DNA-PKcs, Ku, DNA ligase IV, or XRCC4, as well as after chemical inhibition of DNA-PK, indicating that it reflects classical NHEJ; we termed this form of DSB rejoining D-NHEJ to signify its dependence on DNA-PK. Although chemical inhibition, or mutation, in any of these factors delays processing, cells ultimately remove the majority of DSBs using an alternative pathway operating with slower kinetics (half time 2–10 h). This alternative, slow pathway of DSB rejoining remains unaffected in mutants deficient in several genes of the RAD52 epistasis group, suggesting that it may not reflect HDR. We proposed that it reflects an alternative form of NHEJ that operates as a backup (B-NHEJ) to the DNA-PK-dependent (D-NHEJ) pathway. Biochemical studies confirm the presence in cell extracts of DNA end joining activities operating in the absence of DNA-PK and indicate the dominant role for D-NHEJ, when active. These observations in aggregate suggest that NHEJ, operating via two complementary pathways, B-NHEJ and D-NHEJ, is the main mechanism through which IR-induced DSBs are removed from the DNA of higher eukaryotes. HDR is considered to either act on a small fraction of IR induced DSBs, or to engage in the repair process at a step after the initial end joining. We propose that high speed D-NHEJ is an evolutionary development in higher eukaryotes orchestrated around the newly evolved DNA-PKcs and pre-existing factors. It achieves within a few minutes restoration of chromosome integrity through an optimized synapsis mechanism operating by a sequence of protein-protein interactions in the context of chromatin and the nuclear matrix. As a consequence D-NHEJ mostly joins the correct DNA ends and suppresses the formation of chromosome aberrations, albeit, without ensuring restoration of DNA sequence around the break. B-NHEJ is likely to be an evolutionarily older pathway with less optimized synapsis mechanisms that rejoins DNA ends with kinetics of several hours. The slow kinetics and suboptimal synapsis mechanisms of B-NHEJ allow more time for exchanges through the joining of incorrect ends and cause the formation of chromosome aberrations in wild type and D-NHEJ mutant cells.    

1.
Allalunis-Turner MJ, Barron GM, Day RS, Dobler K, Mirzayans R: Isolation of two cell lines from a human malignant glioma specimen differing in sensitivity to radiation and chemotherapeutic drugs. Radiat Res 134:349–354 (1993).
2.
Anderson CW, Dunn JJ, Freimuth PI, Galloway AM, Allalunis-Turner MJ: Frameshift mutation in PRKDC, the gene for DNA-PKcs, in the DNA repair-defective, human, glioma-derived cell line M059J. Radiat Res 156:2–9 (2001).
3.
Asaad NA, Zeng Z-C, Guan J, Thacker J, Iliakis G: Homologous recombination as a potential target for caffeine radiosensitization in mammalian cells: Reduced caffeine radiosensitization in XRCC2 and XRCC3 mutants. Oncogene 19:5788–5800 (2000).
4.
Baumann P, West SC: DNA end-joining catalyzed by human cell-free extracts. Proc natl Acad Sci, USA 95:14066–14070 (1998).
5.
Bennett RA, Gu X-Y, Povirk LF: Construction of a vector containing a site-specific DNA double-strand break with 3′-phosphoglycolate termini and analysis of the products of end-joining in CV-1 cells. Int J Radiat Biol 70:623–636 (1996).
6.
Bezzubova OY, Buerstedde JM: Gene conversion in the chicken immunoglobulin locus: A paradigm of homologous recombination in higher eukaryotes. Experientia 50:270–276 (1994).
7.
Bezzubova O, Silbergleit A, Yamaguchi-Iwai Y, Takeda S, Buerstedde J-M: Reduced X-ray resistance and homologous recombination frequencies in a RAD54–/– mutant of the chicken DT40 cell line. Cell 89:185–193 (1997).
8.
Bryant PE: Enzymatic restriction of mammalian cell DNA using Pvu II and Bam H1: evidence for the double-strand break origin of chromosomal aberrations. Int J Radiat Biol 46:57–65 (1984).
9.
Bryant PE: Use of restriction endonucleases to study relationships between DNA double-strand breaks, chromosomal aberrations and other end-points in mammalian cells. Int J Radiat Biol 54:869–890 (1988).
10.
Buerstedde J-M, Takeda S: Increased ratio of targeted to random integration after transfection of chicken B cell lines. Cell 67:179–188 (1991).
11.
Chang C, Biedermann KA, Mezzina M, Brown JM: Characterization of the DNA double strand break repair defect in scid mice. Cancer Res 53:1244–1248 (1993).
12.
DiBiase SJ, Zeng Z-C, Chen R, Hyslop T, Curran WJ Jr, Iliakis G: DNA-dependent protein kinase stimulates an independently active, nonhomologous, end-joining apparatus. Cancer Res 60:1245–1253 (2000).
13.
Evans JW, Liu XF, Kirchgessner CU, Brown JM: Induction and repair of chromosome aberrations in scid cells measured by premature chromosome condensation. Radiat Res 145:39–46 (1996).
14.
Harrington J, Hsieh CL, Gerton J, Bosma G, Lieber MR: Analysis of the defect in DNA end joining in the murine scid mutation. Mol Cell Biol 12:4758–4768 (1992).
15.
Huang J, Dynan WS: Reconstruction of the mammalian DNA double-strand break end-joining reaction reveals a requirement for an Mre11/Rad50/NBS1-containing fraction. Nucleic Acids Res 30:1–8 (2002).
16.
Jackson SP: Sensing and repairing DNA double-strand breaks. Carcinogenesis 23:687–696 (2002).
17.
Jasin M: Chromosome breaks and genomic instability. Cancer Invest 18:78–86 (2000).
18.
Kabotyanski EB, Gomelsky L, Han J-O, Stamato TD, Roth DB: Double-strand break repair in Ku86- and XRCC4-deficient cells. Nucleic Acids Res 26:5333–5342 (1998).
19.
Khanna KK, Jackson SP: DNA double-strand breaks: signaling, repair and the cancer connection. Nature Genet 27:247–254 (2001).
20.
Labhart P: Nonhomologous DNA end joining in cell-free systems. Eur J Biochem 265:849–861 (1999).
21.
Lees-Miller SP, Godbout R, Chan DW, Weinfeld M, Day RS III, Barron GM, Allalunis-Turner J: Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science 267:1183–1185 (1995).
22.
Lewis LK, Resnick MA: Tying up loose ends: nonhomologous end-joining in Saccharomyces cerevisiae. Mutat Res 451:71–89 (2000).
23.
Lewis LK, Westmoreland JW, Resnick MA: Repair of endonuclease-induced double-strand breaks in Saccharomyces cerevisiae: Essential role for genes associated with nonhomologous end-joining. Genetics 152:1513–1529 (1999).
24.
Loebrich M, Rydberg B, Cooper PK: Repair of x-ray-induced DNA double-strand breaks in specific Not I restriction fragments in human fibroblasts: Joining of correct and incorrect ends. Proc natl Acad Sci, USA 92:12050–12054 (1995).
25.
Natarajan AT: Chromosome aberrations: past, present and future. Mutat Res 504:3–16 (2002).
26.
Natarajan AT, Darroudi F, Mullenders LHF, Meijers M: The nature and repair of DNA lesions that lead to chromosomal aberrations induced by ionizing radiations. Mutat Res 160:231–236 (1986).
27.
Nevaldine B, Longo JA, Hahn PJ: The scid defect results in much slower repair of DNA double-strand breaks but not high levels of residual breaks. Radiat Res 147:535–540 (1997).
28.
Obe G, Pfeiffer P, Savage JRK, Johannes C, Goedecke W, Jeppesen P, Natarajan AT, Martinez-Lopez W, Folle GA, Drets ME: Chromosomal aberrations: formation, identification and distribution. Mutat Res 504:17–36 (2002).
29.
Paques F, Haber JE: Multiple pathways of recombination induced by double-strand breaks in Saccharomyces cerevisiae. Microbiol Mol Biol Rev 63:349–404 (1999).
30.
Pfeiffer P, Göttlich B, Reichenberger S, Feldmann E, Daza P, Ward JF, Milligan JR, Mullenders LHF, Natarajan AT: DNA lesions and repair. Mutat Res 366:69–80 (1996).
31.
Pierce AJ, Stark JM, Araujo FD, Moynahan ME, Berwick M, Jasin M: Double-strand breaks and tumorigenesis. Trends Cell Biol 11:S52–S59 (2001).
32.
Roth DB, Porter TM, Wilson JH: Mechanisms of nonhomologous recombination in mammalian cells. Mol Cell Biol 5:2599–2607 (1985).
33.
Smith GCM, Jackson SP: The DNA-dependent protein kinase. Genes Develop 13:916–934 (1999).
34.
Sonoda E, Sasaki MS, Buerstedde J-M, Bezzubova O, Shinohara A, Ogawa H, Takata M, Yamaguchi-Iwai Y, Takeda S: Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death. EMBO J 17:598–608 (1998).
35.
Takata M, Sasaki M S, Sonoda E, Morrison C, Hashimoto M, Utsumi H, Yamaguchi-Iwai Y, Shinohara A, Takeda S: Homologous recombination and non-homologous end-joining pathways of DNA double-strand breaks. EMBO J 17:5497–5508 (1998).
36.
Takata M, Sasaki MS, Sonoda E, Fukushima T, Morrison C, Albala JS, Swagemakers SM, Kanaar R, Thompson LH, Takeda S: The Rad51 paralog Rad51B promotes homologous recombinational repair. Mol Cell Biol 20:6476–6482 (2000).
37.
Thompson LH, Limoli CL: Origin, recognition, signaling, and repair of DNA double-strand breaks in mammalian cells (Eurekah.com and Kluwer Academic/Plenum Publishers, 2003).
38.
Verkaik NS, Esveldt-van Lange REE, van Heemst D, Brüggenwirth HT, Hoeijmakers JHJ, Zdzienicka MZ, van Gent DC: Different types of V(D)J recombination and end-joining defects in DNA double-strand break repair mutant mammalian cells. Eur J Immunol 32:701–709 (2002).
39.
Wang H, Zeng Z-C, Bui T-A, Sonoda E, Takata M, Takeda S, Iliakis G: Efficient rejoining of radiation-induced DNA double-strand breaks in vertebrate cells deficient in genes of the RAD52 epistasis group. Oncogene 20:2212–2224 (2001a).
40.
Wang H, Zhao-Chong Z, Perrault AR, Cheng X, Qin W, Iliakis G: Genetic evidence for the involvement of DNA ligase IV in the DNA-PK-dependent pathway of non-homologous end joining in mammalian cells. Nucleic Acids Res 29:1653–1660 (2001b).
41.
Wang H, Perrault AR, Takeda Y, Qin W, Wang H, Iliakis G: Biochemical evidence for Ku-independent backup pathways of NHEJ. Nucleic Acids Res 31:5377–5388 (2003).
42.
Xia F, Taghian DG, DeFrank JS, Zeng Z-C, Willers H, Iliakis G: Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining. Proc natl Acad Sci, USA 98:8644–8649 (2001).
43.
Yamaguchi-Iwai Y, Sonoda E, Buerstedde J-M, Bezzubova O, Morrison C, Takata M, Shinohara A, Takeda S: Homologous recombination, but not DNA repair, is reduced in vertebrate cells deficient in RAD52. Mol Cell Biol 18:6430–6435 (1998).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.